Softcat Raises Annual Profit Outlook as AI Infrastructure Demand Surges Amid Chip Shortage WSJ Heard on the Street Launches Eighth Annual StockPicking Contest Bill Gates Discusses Meeting with Trump Elon Musks Dogecoin and Personal History in WSJ Interview Ahead of Memoir IKEI 2026 MA Review First Four Months Signal Cautious Deal Activity EU Green Economy Doubles Output in Under a Decade as Solar Energy Surges to Record Levels Market Analysis Expert Identifies Potential Breakout Stocks Amid Market Dip MED Q1 2026 Earnings EPS Surpasses Estimates Amid Cost Management Efforts Shift4 Payments Q1 2026 Earnings EPS Miss Slightly Offset by Resilient Share Performance CPSS Q4 2025 Earnings EPS Misses Estimates by 105 Stock Rises SEE Q4 2025 Earnings Earnings Beat Driven by Operational Discipline Revenue Details Unavailable Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction RMBI Q1 2026 Earnings Solid EPS Amid Quiet Quarter Stock Edges Lower Intercorp Financial Services IFS Slips 105 as Shares Navigate Between Key Support and Resistance Blackrock Enhanced Global Dividend Trust BOE Holds Steady Near Support as Global Markets Offer Mixed Signals Offerpad Solutions OPAD Edges Lower Testing Key Support at 066 Stellar Bancorp STEL Holds Near Support as Modest Decline Tests Investor Sentiment Waystar Holding Corp WAY Edges Higher as Stock Approaches Key Resistance Zscaler ZS Positioned for Turnaround in Expanding ZeroTrust Security Market COST Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures Stock Declines Alkermes ALKS Holds Steady Near Support After Slight Decline First Financial Bankshares FFIN Holds at 3224 After Marginal Gain Key Levels in Focus TryHard Holdings THH Jumps 74 Testing Key Resistance at 038 Tandy Leather Factory TLF Edges Higher Amid RangeBound Trading Turtle Beach TBCH Surges Over 11 as Gaming Peripheral Demand Shows Promise Arvinas Inc ARVN Consolidates Near Support Amid Low Volatility Weyco Group Holds Steady Near Support as Technicals Suggest Consolidation Inhibikase Therapeutics IKT Faces Selling Pressure as Stock Retreats to 169